Riskpilot← Back to searchSign inGet full accessVIIRAL AS
ASActiveOrg 916538367St Olavs Plass 1, 6002 ÅlesundResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20160 employees
Revenue 2024
NOK 0
EBITDA margin
—
+35% vs 2023
Equity ratio
4.7%
Financial strength
Net profit 2024
NOK -1M
+32% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -994K | +35% |
| Net profit | NOK -1M | +32% |
| Total assets | NOK 4,1M | -6% |
| Equity | NOK 192K | -84% |
| Employees | 0 | — |
Legal name
VIIRAL AS
Org number
916538367
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
11. januar 2016
Share capital
NOK 72 770
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap eller styrets leder alene.
Company purpose
Utvikle og kommersialisere forebyggende virusbehandling basert på patentert teknologi.
Address
St Olavs Plass 1, 6002 Ålesund
Phone
+4791909023
Email
post@viiral.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 1 | 1 953 | 2 368 | 579 | 0 | 339 | 0 | 0 |
| Staff expenses | −899 | −2 107 | −4 660 | −3 880 | −2 665 | −3 046 | −1 614 | −64 | −0 |
| EBITDA | −1 529 | −4 953 | −11 683 | −8 612 | −11 251 | −9 086 | −12 461 | −1 530 | −994 |
| Depreciation & amort. | −0 | −0 | −183 | −195 | −514 | −23 | −0 | −0 | −0 |
| EBIT | −1 529 | −4 953 | −11 866 | −8 806 | −11 765 | −9 109 | −12 461 | −1 530 | −994 |
| Net financials | −5 | −0 | −5 | −4 | −312 | −1 398 | −201 | −18 | −53 |
| Profit before tax | −1 535 | −4 953 | −11 870 | −8 810 | −12 077 | −10 507 | −12 661 | −1 548 | −1 047 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −1 535 | −4 953 | −11 870 | −8 810 | −12 077 | −10 507 | −12 661 | −1 548 | −1 047 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 897 | 2 800 | 4 180 | 8 673 | 3 629 | 4 219 | 4 724 | 4 347 | 4 099 |
| Equity | −1 505 | −806 | 722 | 5 538 | −6 539 | −537 | 2 788 | 1 240 | 192 |
| Long-term debt | 2 150 | 2 002 | 2 | 0 | 0 | 0 | 0 | 0 | 642 |
| Short-term debt | 252 | 1 605 | 3 455 | 3 136 | 10 168 | 4 756 | 1 936 | 3 107 | 3 265 |
| Total debt | 2 402 | 3 606 | 3 457 | 3 136 | 10 168 | 4 756 | 1 936 | 3 107 | 3 907 |
EBITDA margin
-99392900.0%
This company
15.8%
Market median
-629069087% vs market
20162024
Equity ratio
4.7%
This company
38.2%
Market median
-88% vs market
20162024
Return on equity
-544.4%
This company
18.4%
Market median
-3059% vs market
20162024
Net profit margin
-104739500.0%
This company
8.1%
Market median
-1293080347% vs market
20162024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20162024
Debt / equity
20.31×
This company
0.62×
Market median
-3176% vs market
20162024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
OR Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
FF Chief Executive Officer | Chief Executive Officer | 2016 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Life Capitol As | Company | 44.4% | 44.4% | 2024 |
| Individual | 8.4% | 8.4% | 2024 | |
Bjn Holding As | Company | 7.1% | 7.1% | 2024 |
Bfk Holding As | Company | 6.0% | 6.0% | 2024 |
Cavima Invest As | Company | 5.2% | 5.2% | 2024 |
Våge Industri As | Company | 4.6% | 4.6% | 2024 |
Stette Invest As | Company | 3.4% | 3.4% | 2024 |
Eng As | Company | 3.3% | 3.3% | 2024 |
Stayer Consult As | Company | 3.1% | 3.1% | 2024 |
Mimer Medical Ab | Company | 1.1% | 1.1% | 2024 |
Sobona As | Company | 1.1% | 1.1% | 2024 |
| Individual | 1.1% | 1.1% | 2024 | |
| Individual | 1.1% | 1.1% | 2024 | |
Sbc As | Company | 1.1% | 1.1% | 2024 |
Koj Holding As | Company | 1.1% | 1.1% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of VIIRAL AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ola Røthe | Chief Executive Officer | 0 companies |
| Frode Fagermo | Chief Executive Officer | 0 companies |
| Anne Eriksdatter Bjørnebye Vik | Board of Directors | 0 companies |
| Kay Ove Johansen | Board of Directors | 0 companies |
| Bjørn Johan Nes | Board of Directors | 0 companies |
| Oddbjørn Steinar Brungot | Board of Directors | 0 companies |
| Jan Brevig Remmereit | Board of Directors | 0 companies |
| Atle Andreas Remmereit Vasbotn | Board of Directors | 0 companies |